The The Advisory Board Co. (ABCO) Downgraded by Piper Jaffray Cos.

The The Advisory Board Co. (ABCO) Downgraded by Piper Jaffray Cos.

Piper Jaffray Cos. downgraded shares of The Advisory Board Co. (NASDAQ:ABCO) from an overweight rating to a neutral rating in a report issued on Friday. The firm currently has $42.00 price target on the stock. The analysts noted that the move was a valuation call.

Several other equities analysts also recently issued reports on ABCO. Credit Suisse Group AG reaffirmed a buy rating and set a $50.00 price objective on shares of The Advisory Board in a report on Friday, September 16th. William Blair reaffirmed an outperform rating on shares of The Advisory Board in a report on Tuesday, September 27th. Oppenheimer Holdings Inc. reaffirmed an outperform rating and set a $49.00 price objective (up from $45.00) on shares of The Advisory Board in a report on Wednesday, September 28th. Canaccord Genuity set a $50.00 price objective on shares of The Advisory Board and gave the company a buy rating in a report on Wednesday, September 28th. Finally, Barclays PLC increased their price objective on shares of The Advisory Board from $44.00 to $50.00 and gave the company an overweight rating in a report on Friday, September 30th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company. The company presently has a consensus rating of Hold and an average price target of $42.56.

The Advisory Board (NASDAQ:ABCO) opened at 41.25 on Friday. The Advisory Board has a one year low of $18.87 and a one year high of $48.86. The company’s 50-day moving average is $34.32 and its 200 day moving average is $38.94. The company’s market capitalization is $1.66 billion.

The Advisory Board (NASDAQ:ABCO) last released its quarterly earnings results on Tuesday, November 1st. The company reported $0.28 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.40 by $0.12. The firm had revenue of $200.50 million for the quarter, compared to analyst estimates of $203.35 million. The Advisory Board had a negative net margin of 5.77% and a positive return on equity of 11.28%. The firm’s quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.33 EPS. On average, equities analysts anticipate that The Advisory Board will post $1.77 earnings per share for the current year.

In other The Advisory Board news, CEO Robert W. Musslewhite sold 5,500 shares of The Advisory Board stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $33.87, for a total transaction of $186,285.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Cormac F. Miller sold 750 shares of The Advisory Board stock in a transaction dated Wednesday, October 26th. The shares were sold at an average price of $41.63, for a total transaction of $31,222.50. Following the sale, the insider now owns 18,237 shares of the company’s stock, valued at $759,206.31. The disclosure for this sale can be found here. Company insiders own 2.90% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Quantbot Technologies LP acquired a new position in shares of The Advisory Board during the third quarter worth $110,000. BlackRock Inc. boosted its position in shares of The Advisory Board by 16.2% in the second quarter. BlackRock Inc. now owns 3,263 shares of the company’s stock worth $116,000 after buying an additional 455 shares during the period. BlackRock Japan Co. Ltd boosted its position in shares of The Advisory Board by 102.7% in the third quarter. BlackRock Japan Co. Ltd now owns 2,820 shares of the company’s stock worth $126,000 after buying an additional 1,429 shares during the period. BNP Paribas Arbitrage SA boosted its position in shares of The Advisory Board by 111.7% in the third quarter. BNP Paribas Arbitrage SA now owns 3,428 shares of the company’s stock worth $153,000 after buying an additional 1,809 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of The Advisory Board during the third quarter worth $182,000.

The Advisory Board Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value-based care and population health, revenue cycle, clinical operations and supply chain.

Related posts

Leave a Comment